Parallax Volatility Advisers
DCPH

Parallax Volatility Advisers’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Parallax Volatility Advisers’s Portfolio DCPH Stock Details DCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20,000
Closed -$897K – 3669
2021
Q1 		$897K Buy
+20,000
New +$931K ﹤0.01% 2127

Other funds holding DCPH

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Parallax Volatility Advisers's DCPH Position: Q2 2021 in Review

Parallax Volatility Advisers sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2021, closing a stake of 11,051 shares — an estimated $496K sold.

Parallax Volatility Advisers first reported a position in DCPH in Q4 2017 and held it in 3 quarters. The position peaked at $496K in Q1 2021. 147 funds tracked by Wall St. Rank hold DCPH as of Q2 2021.

  • Parallax Volatility Advisers reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Parallax Volatility Advisers sold 11,051 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $496K.
  • Parallax Volatility Advisers first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 3 quarters.
  • Parallax Volatility Advisers's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $496K in Q1 2021.
  • 147 funds tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on Parallax Volatility Advisers's 13F filing for Q2 2021, filed 16 Aug 2021.